Search Sessions and Workshops
  

Thursday, September 23
F21.1.006 Women are Different: Understanding the Complex Female Heart
Time 8:00 AM - 9:00 AM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Expert
CE Hours 1
Therapeutic Area(s)
Acute Care, Cardiometabolic, Cardiovascular, Convenient/Urgent Care, Emergency, Health Promotion/Wellness, Women’s Health
Speaker(s)
Maria C. Kidner, DNP, FNP-BC, FAANP

Heart disease is the number one killer of women, yet under recognized and under treated. Women present late into the active disease process for a variety of social disparities. Plus, providers often lack the understanding of the difference of the female heart and pathology. This presentation is a fast-paced program that intwines the social disparities of women presenting in cardiology with the unique risk factors and presentation of women. The pathophysiology starts on the electron rings of oxygen, then the cellular function, inflammatory responses, and endothelial cell dysfunction to the microvascular coronary artery disease that creates atypical pain patterns to large vessel coronary artery disease with the resulting mortality and morbidity burdens of women. All NPs providing care and guidance to women need to understand the unique risks, cardiac pathology, and importance of preventative cardiology to make a difference in decreasing the number one killer of women.

F21.1.007 The Impact of Racial Trauma on Mental Health
Time 8:00 AM - 9:00 AM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Diversity Training and Cultural Competence, Psychiatric/Mental Health, Social Determinants of Health
Speaker(s)
Irene W. Bean, DNP, FNP-BC, PMHNP-BC, FAANP
This presentation will include the history of Blacks in America. The systemic racism that has remained in place since the end of slavery has resulted in ongoing racial trauma and injustices to Black people, such as racial profiling, voter suppression and overrepresentation in the criminal justice system. Enduring constant prejudice, discrimination and bias takes a toll on one’s mental health. The complexities associated with the re-traumatization of Black people, and the broadened awareness of social and racial injustices, have increased. As the struggle for equality continues, it is critically important for Black people, employers, and organizations to carefully consider the effect of these repeated images and videos on the mental health of black people.
F21.1.008 Change Management for NP Leaders
Time 8:00 AM - 9:00 AM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Competent
CE Hours 1
Therapeutic Area(s)
Leadership
Speaker(s)
Kate Driscoll Malliarakis, PhD, ANP-BC, MAC, FAAN
This presentation examines the concept of change and how it affects the roles of leaders and managers in the workplace. We will explore critical leadership competencies of successful change efforts as well as tips for engaging senior leadership in the change process. Special attention will be made on the timeline for change processes in the organization.
F21.1.009 Pharmacologic Considerations in Acute Respiratory Distress Syndrome
Time 8:00 AM - 9:00 AM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Acute Care, Pharmacology, Respiratory/Pulmonology
Speaker(s)
Anthony M. Angelow, PhD, CRNP, ACNPC, FAEN, FAANP
This presentation will discuss the evidence-based treatment of patients with Acute Respiratory Distress Syndrome (ARDS) with a focus on pharmacologic interventions. This presentation will describe the specific pharmacologic interventions and their evidence-based role and scope in the treatment of ARDS.
F21.1.010 Antipsychotic Reduction in Nursing Homes: An Evidence-based Practice Protocol
Time 8:00 AM - 9:00 AM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Gerontology, Pharmacology, Psychiatric/Mental Health
Speaker(s)
Nancy M. Birtley, DNP, APRN, PMHCNS-BC, PMHNP-BC
Antipsychotic medications pose significant danger to elderly nursing home residents with dementia. The Centers for Medicare and Medicaid Services (CMS) have implemented stringent regulations on the use of antipsychotic medications in nursing homes and nursing homes are at risk for citation or loss of certification for unnecessary or inappropriate use of psychotropic medications, especially antipsychotics. According to CMS, the only appropriate diagnoses for antipsychotic medication use in nursing homes are Huntington’s disease, Schizophrenia and Tourette’s syndrome. Use of antipsychotics to treat other diagnoses such as depression, bipolar disorder, non-Schizophrenic psychotic disorders or psychotic disorders from general medical conditions (i.e., brain tumor, Parkinson’s disease) require detailed documentation to justify the use of antipsychotics. This presentation will review federal regulations regarding antipsychotic medications and risks associated with antipsychotic medications. This presentation will discuss an evidence-based practice protocol that uses a hierarchy of psychotropic medications based on safety and efficacy that can be prescribed as an alternative to antipsychotics to treat dementia behaviors when non-pharmacological interventions are insufficient or unsuccessful. Additionally, proper documentation to support necessary and appropriate use of psychotropic medications, including antipsychotic medications will be reviewed.
F21.1.016 Pharmacology for Obesity Treatment: Today and Tomorrow
Time 9:15 AM - 10:15 AM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Expert
CE Hours 1
Therapeutic Area(s)
Cardiometabolic, Endocrinology, Obesity/Weight Management, Pharmacology, Primary Care
Speaker(s)
Angela K. Golden, DNP, FNP-C, FAANP
Seventy percent (70%) of Americans have pre-obesity or have the serious, chronic and relapsing disease of obesity. This presentation will review the current medication options including off label, obesogenic medication alternatives for treating obesity. A case study approach will be utilized to demonstrate medication selection. Additionally, a look at what is ahead for the treatment of obesity will conclude the presentation.
F21.1.017 COVID-19: How Did We Get Here?
Time 9:15 AM - 10:15 AM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Advanced Beginner
CE Hours 1
Therapeutic Area(s)
COVID 19, Diversity Training and Cultural Competence, Social Determinants of Health
Speaker(s)
Nneka O. Sederstrom, PhD, MPH, MA, FCCP, FCCM
This presentation will look at some historical facts on medicine and racism that have set the stage for the inequities exacerbated in the COVID-19 pandemic.
F21.1.018 Managing Time: Where Did the Day Go?
Time 9:15 AM - 10:15 AM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Business/Professional, Faculty Development/Education, Leadership
Speaker(s)
Loretta A. Penn, Adjunct Professor, George Washington University School of Nursing
Time management behavior is a matter of choice. How you choose to manage your time in order to receive not only greater efficiency but also greater passion and joy, is up to you. We all get the same 24 hours yet some people achieve so much more than others with their time. The question is why is that? What can you do so that you fall into the latter category? During this presentation we will explore tips, techniques and practices that will allow for growth and improvement in how your personal and professional time is applied, with special attention on the impact of social media. Effective time management leads to effective leadership. We cannot manage the time; we can only manage how well we use it.
F21.1.019 Updates in the Pharmacologic Management of Asthma
Time 9:15 AM - 10:15 AM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Expert
CE Hours 1
Therapeutic Area(s)
Allergy/Immunology, Pharmacology, Primary Care, Respiratory/Pulmonology
Speaker(s)
Tracy S. Estes, PhD, DNP, RN, FNP-BC
This presentation will focus on the pharmacologic management of asthma with emphasis on understanding pathophysiology and testing to guide medication management. Clinical exemplars will be used to enhance the understanding of the appropriate medication management options.
F21.1.020 Ten Essentials Every Practitioner Must Know: The Importance of Integrated Care
Time 9:15 AM - 10:15 AM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Primary Care, Psychiatric/Mental Health
Speaker(s)
Mary Ann Nihart, MA, APRN, PMHCNS-BC, PMHNP-BC
The challenges of 2020 produced increasing numbers of individuals impacted by anxiety and depression. Symptoms of trauma and psychosis have been exacerbated and suicide has increased. Most people seek treatment first from their primary care practitioner, but the many complexities of psychiatric disorders necessitate working across specialties. For this reason, essential understandings of neurobiological and psychological underpinnings of depression, symptom recognition, differential diagnosis, challenges in managing symptoms, new options for treatment, and interprofessional collaboration present compelling elements all health care providers must keep in mind. These elements are condensed into the “Ten Essentials” outlined in this presentation.
F21.1.026 The Gut Microbiome and Cardiometabolic Risks
Time 10:30 AM - 11:30 AM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Competent
CE Hours 1
Therapeutic Area(s)
Cardiometabolic, Complementary/Alternative Therapy, Gastroenterology, Pharmacology
Speaker(s)
Christy Blanco, DNP, APRN, WHNP-BC, FAANP
Over the last decade advances have been made in understanding the gut microbiome and the relationship to disease. The presentation will discuss the significance of the gut microbiome and how an imbalance contributes to disease. Growing evidence is linking the gut microbiome to cardiometabolic risks. The presentation will look into the association of the microbiome, cardiometabolic risks and the latest evidence-based treatments.
F21.1.027 BIPOC LGBTQ Folks: Intersectionality, Health Inequity and NP Practice
Time 10:30 AM - 11:30 AM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Advanced Beginner
CE Hours 1
Therapeutic Area(s)
Diversity Training and Cultural Competence, LGBT Health/Transgender, Social Determinants of Health
Speaker(s)
Brian K. Goodroad, DNP, APRN, CNP, FAANP
Too often, when we learn that a person or patient is a member of the lesbian, gay, bisexual, transgender or queer/questioning community, we expect certain beliefs or behaviors based upon group membership. However, the LGBTQ community is incredibly diverse, well-beyond the description of the unitary identify of LGBTQ. The need for a holistic exploration of the community is even more evident for black, indigenous and people of color (BIPOC) who may also identify as LGBTQ. This presentation explores the importance of the holistic view of BIPOC LGBTA folks for whom we provide care as NPs. The importance of NPs understanding of intersectionality for BIPOC LGBTQ folks is explored, health inequities related to this intersectionality are reviewed and a model for holistic nurse practitioner care for BIPOC LGBTQ folks is presented.
F21.1.028 Skillful Communication
Time 10:30 AM - 11:30 AM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Competent
CE Hours 1
Therapeutic Area(s)
Leadership
Speaker(s)
Kate Driscoll Malliarakis, PhD, ANP-BC, MAC, FAAN
In this presentation, there will be a focus on identifying the need for communication skills (both oral and written), finding your voice as an NP, exploring skills for communicating up and down in the organization. We also will examine communication skills in leading teams, especially virtual teams.
F21.1.029 Updates and Case Studies: Sepsis Case Management
Time 10:30 AM - 11:30 AM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Acute Care, Pharmacology
Speaker(s)
Anthony M. Angelow, PhD, CRNP, ACNPC, FAEN, FAANP
This presentation will provide an overview of the evidence-based management of sepsis with a focus on pharmacologic interventions. This presentation will describe the specific pharmacologic interventions and their evidence-based role and scope in the treatment of patients with sepsis.
F21.1.030 Pharmacogenomics: Precision Medicine & Depression Treatment
Time 10:30 AM - 11:30 AM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Expert
CE Hours 1
Therapeutic Area(s)
Genetics/Genomics, Pharmacology, Psychiatric/Mental Health
Speaker(s)
Josh Hamilton, DNP, RN-BC, FNP-C, PMHNP-BC, CTMH, CNE, FAANP
Pharmacogenomics is the study of how genes affect a person’s response to drugs. This science has given rise to the practice of “precision medicine,” which combines pharmacology (the study of medication) and genomics (the study of genes and their functions) to help prescribers make more personalized medication choices. These include which medications to prescribe to different individuals and what doses will have the best effects. This presentation integrates concepts of neurobiology and neuropathology with genetics and genomics to produce new models for diagnosis and personalized treatment for major depressive disorder. The results of the GUIDED study are presented to highlight the efficacy of this approach.
F21.1.036 Hyperlipidemia: Current Trends in Treatment
Time 1:15 PM - 2:15 PM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Cardiometabolic, Cardiovascular, Endocrinology, Health Promotion/Wellness, Pharmacology, Primary Care
Speaker(s)
Colleen Walsh-Irwin, DNP, RN, ANP-BC, AACC, FAANP
This presentation will review the most recent guidelines for the management of hyperlipidemia including targets for lipid levels based on patient risk factors. We will discuss how to manage patients who are “stating intolerant” and treatment strategies for getting patients to goal. The medications that have recently been approved for hyperlipidemia including injectable agents, as well as the newest oral agents that are available will be reviewed. Included in this discussion will be tips for getting these medications approved for patient use.
F21.1.037 The Bridge Over Troubled Waters: Exploring Disparities and Building Trust Amongst BIPOC Populations at End of Life
Time 1:15 PM - 2:15 PM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Diversity Training and Cultural Competence, Palliative/End-of-Life
Speaker(s)
Rachel Butler, ARNP, FNP-BC
With our ever-expanding landscape of medical advancements, our elderly or chronically ill populations have many routes to extend life longer than in previous generations. We insert and bypass, dialyze and reconstruct. But what happens when we cannot fix, heal or reverse? Palliative care aims to relieve pain and suffering and increase quality of life while ushering the most vulnerable patients to a path of comfort that encompasses their physical, mental and spiritual well-being. While palliative care and hospice care are readily available, populations of color are less apt to receive this high-quality specialized care at or towards end of life. With likely many factors at play, we will explore how trust, or lack thereof, as well as misconceptions and failed communication ultimately lead to this disparity.
F21.1.038 Expanding Your Emotional Intelligence
Time 1:15 PM - 2:15 PM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Competent
CE Hours 1
Therapeutic Area(s)
Business/Professional, Faculty Development/Education, Leadership
Speaker(s)
Jean Johnson, PhD, RN, FAAN; Loretta A. Penn, Adjunct Professor, George Washington University
This presentation will critically analyze the importance of emotional intelligence in leader effectiveness. Each of the competencies that provide the collective of emotional intelligence will be discussed. The participants will participate in an exercise to assess their level of emotional intelligence and identify one activity to enhance a selected competency in order to increase their effectiveness in building teams and working with others including their supervisor.
F21.1.039 Medical Marijuana and CBD: The Blunt Basics
Time 1:15 PM - 2:15 PM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Competent
CE Hours 1
Therapeutic Area(s)
Complementary/Alternative Therapy, Pharmacology
Speaker(s)
Andrew M. Peterson, PharmD, PhD, FCPP
The basic pharmacology of THC and CBD will be discussed. A review of the commonly used dosage forms, the pros/cons to their use and the basic pharmacokinetic differences will be introduced. Further, the presentation will address the endocannabinoid system and how THC and CBD interact with that system. The side effects and drug interaction profiles of THC and CBD will be presented.
F21.1.040 The Neurobiology of Trauma: Basis of Symptom Development
Time 1:15 PM - 2:15 PM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Competent
CE Hours 1
Therapeutic Area(s)
COVID 19, Neurology, Pharmacology, Psychiatric/Mental Health
Speaker(s)
Sattaria (Tari) Dilks, DNP, APRN, PMHNP-BC, FAANP
Trauma, especially extended or repetitive trauma, sets the stage for neurobiological changes that inform the observable symptoms, especially those associated with Post Traumatic Stress Disorder (PTSD). This knowledge assists with determination of medication or therapeutic approaches to facilitate recovery and resiliency. We are currently in unprecedented times due to trauma associated with pandemic and unknown sequala of both the pandemic and COVID 19. We will explore what PCPs might expect to see in the future based on our past knowledge of widespread traumatic events and the early data on a worldwide pandemic which has affected every area of life as we have known it. We will discuss screening tools, treatment strategies, and when there is a need to refer.
F21.1.046 Multidisciplinary Case Studies for Cardiometabolic Disease
Time 2:30 PM - 3:30 PM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Expert
CE Hours 1
Therapeutic Area(s)
Acute Care, Cardiometabolic, Cardiovascular, Endocrinology, Health Promotion/Wellness, Obesity/Weight Management, Pharmacology
Speaker(s)
Speakers: Colleen Walsh-Irwin, DNP, RN, ANP-BC, AACC, FAANP; Angela R. Thompson, DNP, FNP-C, BC-ADM, CDCES, FAANP; Angela K. Golden, DNP, FNP-C, FAANP. Moderator: Margaret (Midge) T. Bowers, DNP, FNP-BC, FAANP, FAAN

This panel discussion will include case studies of complex patients with cardiometabolic diseases. A round table discussion including a panel of cardiovascular, obesity and endocrine subject matter experts will review case studies and treatment plans. We will discuss how treatment decisions for one chronic disease can affect decision making for another disease. This moderated panel discussion will be interactive.

F21.1.047 Racism, COVID-19 and the Crisis of Standards of Care
Time 2:30 PM - 3:30 PM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Advanced Beginner
CE Hours 1
Therapeutic Area(s)
COVID 19, Diversity Training and Cultural Competence, Social Determinants of Health
Speaker(s)
Nneka O. Sederstrom, PhD, MPH, MA, FCCP, FCCM
In this presentation we will discuss how the original crisis standards of care and scoring protocols promoted inequities and exacerbated systemic racism at the beginning of the COVID-19 pandemic.
F21.1.048 The Gifts of Mentoring
Time 2:30 PM - 3:30 PM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Business/Professional, Faculty Development/Education, Leadership
Speaker(s)
Loretta A. Penn, Adjunct Professor, George Washington University
The true gift of mentoring is that it provides value at so many levels for the mentee, mentor, supervisors and the organization for which they work. Mentees have an opportunity to learn from someone they trust who has achieved a level of respect and expertise admired by their peers and superiors. Mentors have an opportunity to expand their professional knowledge and skills through their instruction and facilitation of others. The organization benefits by further developing and disseminating the wealth of talent, skill and knowledge of its employees, strengthening the learning curve at multiple levels, and impacting productivity and profitability. Everyone wins. During this presentation, we will focus on the key elements of a successful mentoring relationship, benefits to each party and the identifiable skills that enable learning and change to successfully take place.
F21.1.049 Updates in the Pharmacologic Management of COPD
Time 2:30 PM - 3:30 PM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Expert
CE Hours 1
Therapeutic Area(s)
Pharmacology, Primary Care, Respiratory/Pulmonology
Speaker(s)
Tracy S. Estes, PhD, DNP, RN, FNP-BC
This presentation will focus on the pharmacologic management of chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema. There will be special emphasis placed on understanding pathophysiology and testing to guide medication management. Clinical exemplars will be used to enhance the understanding of the appropriate medication management options.
F21.1.050 Neuroscience & Neuroplasticity: The Keys to Treating Substance Use Disorders
Time 2:30 PM - 3:30 PM (Thursday, 9/23)
Presentation Type Concurrent Presentation
Content Level Expert
CE Hours 1
Therapeutic Area(s)
Addiction/Substance Abuse Disorder, Pharmacology, Psychiatric/Mental Health
Speaker(s)
Laura G. Leahy, DrNP, APRN, FAANP, FAAN

Patients struggle with addictions and substance use disorders (SUDs) and utilize all disciplines of the health care spectrum. This presentation will focus on the most commonly abused substances including opioids. APRNs attending this presentation will gain an understanding of the complexities and neuroplasticity of the brain related to SUDs which "set the stage" for pharmaceutical intervention. A review of medications for various substance use disorders as well as techniques to pharmaceutically manage withdrawal and overdose will be presented.


Friday, September 24
F21.2.006 Taking a Pregnant Pause: Addressing the Intersection of Cardiology and Obstetrics
Time 8:00 AM - 9:00 AM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Cardiometabolic, Cardiovascular, Reproductive Health, Women’s Health
Speaker(s)
Margaret (Midge) T. Bowers, DNP, FNP-BC, FAANP, FAAN

This presentation will review the physiologic and physical exam changes of pregnancy and the effect on the cardiovascular system. Discussion will focus on management of peripartum cardiomyopathy, maternal hypertension, maternal valve disease and maternal history of congenital heart disease using a cardiovascular lens. Discussion will include pharmacology considerations in this population including contraceptive options.

F21.2.007 Inclusive Lactation Care for LGBTQ and BOPIC Communities
Time 8:00 AM - 9:00 AM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Diversity Training and Cultural Competence
Speaker(s)
Jamille Nagtalon-Ramos, EdD, MSN, WHNP-BC, IBCLC, FAANP
Strategies to provide inclusive lactation care for LGBT and BIPOC communities will be covered in this presentation. Cultural humility will be the framework used in the discussion.
F21.2.008 Creating a Culture of Safety and Quality
Time 8:00 AM - 9:00 AM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Competent
CE Hours 1
Therapeutic Area(s)
Business/Professional, Faculty Development/Education, Leadership
Speaker(s)
Jean Johnson, PhD, RN, FAAN
This presentation will challenge participants to lead quality improvement efforts in their practices as well as build a culture of quality and safety. The critical importance of NPs leading quality efforts will be discussed. Tools to identify problems and create interventions to address quality issues will be presented. Instruments to assess the culture of quality will be discussed. Participants will identify strategies to build cultures of quality and safety in their practices.
F21.2.009 Practical Pharmacogenetics
Time 8:00 AM - 9:00 AM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Competent
CE Hours 1
Therapeutic Area(s)
Genetics/Genomics, Pharmacology
Speaker(s)
Andrew M. Peterson, PharmD, PhD, FCPP

In practice, it seems that incorporating pharmacogenetics (PGx) into daily routines can be difficult. This presentation will review the basics principles of PGx and describe the rationale and process for using PGx in clinical practice. The learner will also be guided through interpreting PGx results and applying those results to patient cases.

F21.2.010 When ADHD is Really TRAUMA: Differential Diagnosis and Special Treatment Considerations for Children & Adolescents
Time 8:00 AM - 9:00 AM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Adolescent Health, Health Promotion/Wellness, Pediatric, Pharmacology, Psychiatric/Mental Health
Speaker(s)
Erica S. Ramey, DNP, PMHNP
This presentation will assist the mental health professional with differentiating between ADHD, trauma symptoms and related disorders. Discussion will include treatment strategies that may exacerbate and/or alleviate related symptoms based on the underlying condition.
F21.2.016 Medical Management of Obesity along with Devices and Surgery
Time 9:15 AM - 10:15 AM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Adolescent Health, Cardiometabolic, Endocrinology, Obesity/Weight Management, Pharmacology, Primary Care
Speaker(s)
Angela K. Golden, DNP, FNP-C, FAANP
This presentation will provide the participant with an overview of the current available devices and surgery. Additionally, the role of the medical management of obesity in conjunction with devices and surgery will be covered. Case studies will be utilized to demonstrate the application of current practice.
F21.2.017 The Link Between Your Identity and How You "Show Up" as a Leader
Time 9:15 AM - 10:45 AM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Advanced Beginner
CE Hours 1.5
Therapeutic Area(s)
Business/Professional, Diversity Training and Cultural Competence, Leadership
Speaker(s)
Emma M. Flack, EdD
Our identities not only shape how we interact within our chosen circles, but also how we show up as leaders in our professional and clinical environments. As administrators, clinicians and practitioners, the social groups that we belong to have an impact on our behaviors, cognitive decision-making processes, and our consideration of different perspectives. Conversely, our identity groups also impact how we are perceived and treated by others. We will explore social identity and leadership, the conscious and subconscious ways that we interact within our interdisciplinary teams, and our potential leadership opportunities towards our patients and the communities that we serve. In this interactive workshop, we will gain self-awareness by mapping social identities and exploring how our identities are connected to our effectiveness as a leader; understand how our visible and invisible identities support our leadership – and how they may create bias or blind spots; uncover opportunities to foster a culture of diversity, equity and inclusion in our scope of influence as a leader-practitioner; and challenge our thinking through small-group sense-making discussions – and identify thought partners and accountability partners as we commit to individual actions.
F21.2.018 Identifying Your Leadership Style
Time 9:15 AM - 10:15 AM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Advanced Beginner
CE Hours 1
Therapeutic Area(s)
Leadership
Speaker(s)
Kate Driscoll Malliarakis, PhD, ANP-BC, MAC, FAAN
In this presentation, we will explore leadership theories and traits, understand how change theories inform our leadership practices, examine authentic leadership, and explore power. We will close with a discussion on executive presence and how to use your gravitas as a leader.
F21.2.019 Drugs as the Etiology: Case Studies in Drug-Induced Symptom Presentation
Time 9:15 AM - 10:15 AM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Expert
CE Hours 1
Therapeutic Area(s)
Acute Care, Emergency, Pharmacology, Primary Care, Psychiatric/Mental Health
Speaker(s)
Sally K. Miller, PhD, APRN, FNP-BC, AGACNP-BC, AGPCNP-BC, PMHNP-BC, FAANP
Medication adverse effects are a commonly identified cause of patient complaints, and several are well known and easily identified. New onset lightheadedness: look for the new antihypertensive. New onset constipation: look for the anticholinergic. Unfortunately, sometimes the relationship is not apparent, or we do not know about the culprit medication. This presentation presents case studies from everyday settings in which drugs are the “not so obvious” etiology of symptoms that led to invasive, expensive, and/or unnecessary work-ups.
F21.2.020 Common Psychotropic Medications in Primary Care: What the PCP Needs to Know
Time 9:15 AM - 10:15 AM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Competent
CE Hours 1
Therapeutic Area(s)
COVID 19, Pharmacology, Primary Care, Psychiatric/Mental Health
Speaker(s)
Sattaria (Tari) Dilks, DNP, APRN, PMHNP-BC, FAANP
Primary care providers assist with the provision of care for too many psychiatric patients. It is important to understand the neurobiology in the neurochemistry in making treatment decisions regarding psychotropic medications. We will discuss when mental illness is within the scope of a primary care provider’s practice, mechanisms of action and decision-making strategies regarding medication choices and when to refer to psychotherapy. The focus will primarily be on antidepressants, anxiolytics and atypical antipsychotics. Additionally, we will discuss appropriate screening tools for a PCP office setting.
F21.2.026 Non-Alcohol Fatty Liver Disease
Time 10:30 AM - 11:30 AM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Competent
CE Hours 1
Therapeutic Area(s)
Cardiometabolic, Gastroenterology, Primary Care
Speaker(s)
Amanda Chaney, DNP, APRN, FAANP, AF-AASLD
Nonalcoholic fatty liver disease (NAFLD) is becoming more common in the United States and worldwide. There is a wide spectrum of disease progression when discussing NAFLD. The mainstay of treatment is lifestyle modification. There are ongoing research endeavors that are promising. This presentation will discuss important information for the primary care provider to offer best care for the patient with NAFLD.
F21.2.028 Leadership, Passion and Vision
Time 10:30 AM - 11:30 AM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Advanced Beginner
CE Hours 1
Therapeutic Area(s)
Leadership
Speaker(s)
Kate Driscoll Malliarakis, PhD, ANP-BC, MAC, FAAN
This presentation will address understanding leadership, finding your passion, and creating a vision for yourself. We will examine readiness for leadership, navigating leadership within your organization, exploring personal strengths and opportunities in your leadership practice, managing chaos and people. The focus will be on using your passion to grow your leadership practice.
F21.2.029 The Legal Implication of Opioid Prescribing
Time 10:30 AM - 11:30 AM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Competent
CE Hours 1
Therapeutic Area(s)
Acute Care, Addiction/Substance Abuse Disorder, Adolescent Health, Emergency, Faculty Development/Education, Hospitalist/In-Patient, Integrative Health, Military/Uniformed Services Health Care, Pain Management, Pharmacology, Primary Care, Psychiatric/Mental Health
Speaker(s)
Albert Rundio, PhD, DNP, APRN-BC, NEA-BC, CARN-AP, FNAP, FAAN

Repeated in F21.3.019. This presentation will discuss the legal implications of prescribing opioid medications. As every state varies on legislative issues regarding this topic, one state will be utilized as an example. The importance of state mandated Physician Drug Monitoring Programs (PDMP) will be discussed. Case studies will also be presented.

F21.2.030 Keeping It Simple: The Power of Brief Therapeutic Interventions
Time 10:30 AM - 11:30 AM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Genetics/Genomics, Pharmacology, Psychiatric/Mental Health
Speaker(s)
Josh Hamilton, DNP, RN-BC, FNP-C, PMHNP-BC, CTMH, CNE, FAANP
Compelling evidence suggests that both medications and therapeutic interventions are effective in the treatment of psychiatric disorders. The current “state of the science” involves multiple modalities to produce better outcomes than those observed with the use of either psychopharmacology or therapy alone. Nurse practitioners in all settings need to understand how various therapeutic interventions can profoundly influence clients’ ability to cope and change. Using the unifying framework developed by Hubble, Duncan and Miller, we examine the four common elements that account for much of the improvement seen in clients, regardless of the approach taken. These constructs are applied to a variety of simple, brief approaches that are easily enacted -- and easily adapted -- to any patient encounter.
F21.2.036 Oral Care and Its Effect on Cardiometabolic Disease
Time 1:30 PM - 2:30 PM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Cardiometabolic, Otolaryngology
Speaker(s)
Maria Colandrea, DNP, NP-C, CCRN, CORLN, FAANP, FRCSI
Poor oral health has detrimental effects on systemic health. Periodontitis, which is a chronic inflammatory disease of the mouth, shares chronic inflammatory characteristics in cardiometabolic disease. This presentation will review pathophysiology, link between periodontal disease and cardiometabolic inflammation, and discuss mitigating strategies to improve oral health.
F21.2.037 Racism as a Structural Determinant of Health
Time 1:30 PM - 2:30 PM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Advanced Beginner
CE Hours 1
Therapeutic Area(s)
Diversity Training and Cultural Competence, Faculty Development/Education, Social Determinants of Health
Speaker(s)
Sandra Davis, PhD, DPM, ACNP-BC, FAANP; Danielle McCamey, DNP, CRNP, ACNP-BC, FCCP
Addressing racism as a root causes of disparities, inequities and injustices is essential for achieving health equity. This presentation focuses on racism as both a structural and a social determinant of health. It contextualizes systemic racism, both historically and presently, and provides strategies for building structural competency and dismantling systemic racism.
F21.2.038 Navigating Organizational Leadership
Time 1:30 PM - 2:30 PM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Competent
CE Hours 1
Therapeutic Area(s)
Business/Professional, Faculty Development/Education, Leadership
Speaker(s)
Jean Johnson, PhD, RN, FAAN
Participants will explore the meaning of effective organizational leadership. Presentation and discussion will include analysis of the multiple roles of leaders and self-assessment tools useful in becoming effective organizational leaders. Skills essential to effective leadership within organizations will be presented and discussed. Future trends and the impact on organizations and the NP role within organizations will be explored.
F21.2.039 The Pharmacology of Smoking Cessation Drugs and Impact of Vaping
Time 1:30 PM - 2:30 PM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Addiction/Substance Abuse Disorder, Health Promotion/Wellness, Pharmacology
Speaker(s)
Andrew M. Peterson, PharmD, PhD, FCPP
This program is designed to provide nurse practitioners the foundational and practical knowledge to prescribe and monitor drug therapy use to treat nicotine dependence. In addition to the basic pharmacology of the drugs, this program will review the side/adverse effects as well as the drug-drug interactions seen when using common agents for smoking cessation. Further the risks and benefits of e-cigarettes/vaping as a tool will be discussed.
F21.2.040 Glutamate in Treatment-resistant Depression: The Who and What of Es/ketamine
Time 1:30 PM - 2:30 PM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Expert
CE Hours 1
Therapeutic Area(s)
Psychiatric/Mental Health
Speaker(s)
Mary Ann Nihart, MA, APRN, PMHCNS-BC, PMHNP-BC
Many limitations exist in analyzing the science around treatment resistant depression. A number of elements, such as accurate diagnosis, are key in effective treatment, but most important are the advances in understanding new neurobiology. Glutamate pathways and the interaction with other neuro-messengers reveals new understandings and potential therapies. This presentation reviews the research and underpinnings of advances in treatment resistant depression, outlines available glutaminergic treatments such as ketamine and esketamine, and potential interventions of the future.
F21.2.046 Adult Onset Type 1 Diabetes: How To Navigate Diagnosis and Management in Primary Care
Time 2:45 PM - 3:45 PM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Autoimmune Disorders, Cardiometabolic, Endocrinology, Pharmacology, Primary Care
Speaker(s)
Angela R. Thompson, DNP, FNP-C, BC-ADM, CDCES, FAANP

Type 1 Diabetes is thought of as a condition that primarily occurs in childhood and adolescence, but this condition does occur in adults and is often misdiagnosed as Type 2 diabetes.  In fact, Type 1 diabetes is equally likely to happen in the first six decades of life with over 42% of all cases occurring between the ages of 40-60 years of age. And current estimates indicate that as much as 40% of adults diagnosed with Type 2 diabetes actually have Type 1 diabetes. It is critical that primary care nurse practitioners (NPs) understand the distinguishing characteristics of Type 1 diabetes in adults so early detection and recognition can occur.  It is equally important NPs appreciate the unique challenges associated with the management and treatment of this unique population.  This presentation will utilize case studies to demonstrate the practical application of guidelines and best practices in the primary care setting for the management of Type 1 diabetes in adults.

F21.2.047 The NP’s Role in Optimizing Maternal Care for BIPOC
Time 2:45 PM - 3:45 PM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Diversity Training and Cultural Competence, LGBT Health/Transgender, Social Determinants of Health, Women’s Health
Speaker(s)
Jamille Nagtalon-Ramos, EdD, MSN, WHNP-BC, IBCLC, FAANP

By 2045, people of color will be the majority of the United States population; however, racial and ethnic disparities in women’s health continue to persist. This presentation will address the racial and ethnic disparities in maternal care and the role of nurse practitioners in optimizing and improving maternal care for BIPOC communities.

F21.2.048 Leading and Building High-Performance Collaborative Teams in a Multi-Generational Environment
Time 2:45 PM - 3:45 PM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Expert
CE Hours 1
Therapeutic Area(s)
Business/Professional, Faculty Development/Education, Leadership
Speaker(s)
Loretta A. Penn, Adjunct Professor, George Washington University
There are five generations making up our workplace today. Managing intergenerational challenges while creating a collaborative and teamwork environment will take time and commitment from you personally as a leader and at all levels within your work environment. Research, backed up by life experience, tells us that the different generations each come at life, work and relationships from a distinct angle. During this presentation, you will have an opportunity to discuss what some of the key intergenerational challenges are and why generation impacts values and behaviors as well as why these differences matter; what it means to you in how you manage and work most effectively with each. You will discuss and learn ways to communicate and frame your interaction with each person in a way that connects best and provides the greatest opportunity for a positive outcome.
F21.2.049 Medication Assisted Treatment: Pharmacologic Management of Substance Use Disorders
Time 2:45 PM - 3:45 PM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Competent
CE Hours 1
Therapeutic Area(s)
Acute Care, Addiction/Substance Abuse Disorder, Adolescent Health, Faculty Development/Education, Military/Uniformed Services Health Care, Pain Management, Pharmacology, Primary Care, Psychiatric/Mental Health
Speaker(s)
Albert Rundio, PhD, DNP, APRN-BC, NEA-BC, CARN-AP, FNAP, FAAN
This presentation discusses current evidence-based medication assisted treatment for the pharmacologic management of substance use disorders. Current evidence-based pharmacologic management for the detoxification of clients with substance use disorders will be discussed. Relapse preventions strategies inclusive of current evidence-based pharmacologic agents will be presented. The importance of accurate assessment for the client with substance use disorders will also be presented.
F21.2.050 Dementia and Delirium: Identification and Intervention from a Psychiatric Perspective
Time 2:45 PM - 3:45 PM (Friday, 9/24)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Acute Care, Gerontology, Hospitalist/In-Patient, Pharmacology, Psychiatric/Mental Health
Speaker(s)
Nancy M. Birtley, DNP, APRN, PMHCNS-BC, PMHNP-BC
Delirium and dementia, both considered neurocognitive disorders in the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5), can be challenging to diagnose. Delirium is often superimposed on dementia and those with dementia are particularly vulnerable to delirium. Often dementia is diagnosed inappropriately during a delirium. Dementia has multiple etiologies and understanding the symptomatology of each dementia is key to proper diagnosis treatment. This presentation describes the diagnosis of dementia and delirium based on the American Psychiatric Association’s DSM-5. In this presentation, DSM-5 criteria for various neurocognitive disorders will be reviewed including neurocognitive disorders due to Alzheimer’s disease, frontotemporal lobar degeneration, Lewy body disease, vascular disease, traumatic brain injury, substance/medication use, HIV infection, prion disease, Parkinson’s disease, Huntington’s disease, and other medical conditions. In addition, differentiating delirium from dementia will be discussed with emphasis on the elderly population as many psychotropic drugs used to mitigate symptoms of delirium have the potential for significant adverse effects in the elderly.

Saturday, September 25
F21.3.006 Cardiometabolic Risk Factors for Aortic Stenosis
Time 8:45 AM - 9:45 AM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Competent
CE Hours 1
Therapeutic Area(s)
Acute Care, Cardiometabolic, Cardiovascular, Gerontology, Primary Care
Speaker(s)
Mary McGreal, DNP, RN, ANPC
Aortic stenosis is an evolving epidemic in cardiovascular medicine. The only treatments for aortic stenosis are either valve replacement surgery or transcatheter aortic valve replacement. Because no medical therapy is available, identification of modifiable risk factors for aortic stenosis is highly desirable. The pathogenesis and risk factors for aortic stenosis are not completely understood. Nevertheless, it is now recognized that aortic stenosis is not merely an inevitable consequence of aging, and available evidence indicates possible links with atherosclerotic risk factors including hypertension, dyslipidemia and diabetes. Unraveling the risk factors contributing to aortic stenosis incidence and progression will be key in designing preventative measures for slowing down its progression.
F21.3.007 Seeing the Big Picture: Integrating Social Determinants of Health into Your Clinical Practice
Time 8:45 AM - 9:45 AM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Expert
CE Hours 1
Therapeutic Area(s)
Acute Care, COVID 19, Diversity Training and Cultural Competence, Health Promotion/Wellness, Primary Care, Social Determinants of Health
Speaker(s)
Courtney Pladsen, DNP, FNP-BC, RN
Whether it is Covid-19 infection rates, maternal mortality, or cancer survival rates, racial inequities are pervasive in our health system. In this discussion we will take a deep dive exploring how institutionalized racism is a social determinant of health and we will review the most up to date research for integrating social determinant of health screening into clinical practice. By better understanding patients' social determinants of health, we can help create a more equitable system and improve health outcomes for our patients.
F21.3.008 Ethics for Leaders in Healthcare
Time 8:45 AM - 9:45 AM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Business/Professional, Leadership
Speaker(s)
Joyce M. Knestrick, PhD, FNP-BC, FAANP, FAAN
This presentation will discuss health care ethics and the ethical decisions made by health care leaders. An overview of ethical decision making will be discussed. The process of making ethical decisions and the importance for leaders will be reviewed. Case studies related to the application and synthesis of the material will be presented.
F21.3.009 Pharmacologic Management of Sleep Disorders: Targeting the Physiology
Time 8:45 AM - 9:45 AM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Acute Care, Pharmacology, Primary Care, Psychiatric/Mental Health, Sleep Disorder
Speaker(s)
Sally K. Miller, PhD, APRN, FNP-BC, AGACNP-BC, AGPCNP-BC, PMHNP-BC, FAANP
Sleep disorders are a common symptom in the primary care setting, and pharmacotherapeutic options abound! Benzodiazepine receptor agonists, melatonin-based options, antidepressants, antipsychotics, nutraceuticals are just a few available options. Considering the physiology of sleep and sleep disorders provides a foundation for the best medication selection. This presentation reviews the physiology of sleep disorders and evaluates best drug options based on treatment target.
F21.3.010 A Structured Approach to De-prescribing Psychiatric Medication
Time 8:45 AM - 9:45 AM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Expert
CE Hours 1
Therapeutic Area(s)
Adolescent Health, Pharmacology, Psychiatric/Mental Health
Speaker(s)
Erica S. Ramey, DNP, PMHNP
This presentation will help the provider identify individuals who are good candidates for reducing medications and provide the prescriber with a structured approach to the deprescribing process. Practical application and case examples will be provided.
F21.3.016 Managing Hypertension in Adults Utilizing an Evidence-Based Approach
Time 10:00 AM - 11:00 AM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Acute Care, Cardiometabolic, Cardiovascular, Health Promotion/Wellness, Hospitalist/In-Patient, Pharmacology
Speaker(s)
Jennifer Ballard-Hernandez, DNP, FACC, FAHA, FAANP
Hypertension remains a prevalent disease in the United States that is associated with significant morbidity and mortality. Nurse practitioners need to be knowledgeable of current treatment options to prevent cardiovascular sequela associated with untreated hypertension. Using interactive case-based tutorials, participants will review the current American College of Cardiology/American Heart Association guideline on the management of hypertension, emphasizing practical approaches and clinical pearls to translate scientific evidence into everyday practice to improve patient outcomes. Emphasis will be on treatment goals for adults based on recent evidence, the benefits and risks of lower targets for systolic blood pressure, and the importance of blood pressure monitoring. Use of lifestyle modification and guideline-directed medical therapy will be discussed to reduce cardiovascular events and improve patients’ quality of life.
F21.3.017 Implicit Bias and Clinical Practice Decision Making
Time 10:00 AM - 11:00 AM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Competent
CE Hours 1
Therapeutic Area(s)
Diversity Training and Cultural Competence, Social Determinants of Health
Speaker(s)
Barbara A. Todd, DNP, ACNP-BC, FAANP, FAAN

This presentation will explore the impact of implicit bias in clinical decision making. Case studies will be utilized to explore the relationship between clinician bias, treatment decisions, health care disparities and patient outcomes.

F21.3.018 Bullying and Incivility in the Workplace
Time 10:00 AM - 11:00 AM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Competent
CE Hours 1
Therapeutic Area(s)
Business/Professional, Diversity Training and Cultural Competence, Faculty Development/Education, Leadership, Transition to Practice
Speaker(s)
Jean Johnson, PhD, RN, FAAN
This presentation will define and describe bullying and incivility behavior as well as address the roots of this behavior. Recognition of these behaviors will be emphasized as well as strategies to eliminate the behaviors. Those strategies will include addressing behaviors in the moment, integrating policies and processes for addressing the behaviors, and role modeling. Discussion will include how to manage a boss who is a bully as well as doing a self-check on one’s own behaviors.
F21.3.019 The Legal Implication of Opioid Prescribing
Time 10:00 AM - 11:00 AM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Competent
CE Hours 1
Therapeutic Area(s)
Acute Care, Addiction/Substance Abuse Disorder, Adolescent Health, Emergency, Faculty Development/Education, Hospitalist/In-Patient, Integrative Health, Military/Uniformed Services Health Care, Pain Management, Pharmacology, Primary Care, Psychiatric/Mental Health
Speaker(s)
Albert Rundio, PhD, DNP, APRN-BC, NEA-BC, CARN-AP, FNAP, FAAN

Repeat of F21.2.029. This presentation will discuss the legal implications of prescribing opioid medications. As every state varies on legislative issues regarding this topic, one state will be utilized as an example. The importance of state mandated Physician Drug Monitoring Programs (PDMP) will be discussed. Case studies will also be presented.

F21.3.020 Women’s Mental Health: PMDD, Pregnancy and Perimenopause
Time 10:00 AM - 11:00 AM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Expert
CE Hours 1
Therapeutic Area(s)
Pharmacology, Psychiatric/Mental Health, Reproductive Health, Women’s Health
Speaker(s)
Laura G. Leahy, DrNP, APRN, FAANP, FAAN

The female reproductive hormones fluctuate widely across the lifespan and frequently contribute to disruption of mood, cognition, pleasure and overall quality of life. This presentation will explore the impact of the reproductive hormonal system on mood across the female lifespan. We will explore various psychotropic medications and how they may be used to stabilize mood fluctuations during PMS, PMDD, Pregnancy and Peri-menopause.

F21.3.026 Hypertriglyceridemia and the Role of Omega 3s in ASCVD Risk Reduction
Time 11:15 AM - 12:15 PM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Cardiometabolic, Cardiovascular, Endocrinology, Pharmacology, Primary Care
Speaker(s)
Carrie Palmer, DNP, RN, ANP-BC, CDE
This presentation will focus on the role of triglycerides in atherosclerotic risks. The speaker will include a review of literature on cardiovascular outcomes specific to triglyceride lowering. She will end with implications for clinical practice for nurse practitioners.
F21.3.027 Navigating the U.S. Health Care System as a Person with an Acquired Disability
Time 11:15 AM - 12:15 PM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Advanced Beginner
CE Hours 1
Therapeutic Area(s)
Acute Care, Diversity Training and Cultural Competence, Emergency, Occupational Health, Social Determinants of Health, Transition to Practice
Speaker(s)
Laka Mitiku Negassa, MPH
I will be sharing my personal experience of navigating the U.S. health care system as a Black immigrant woman with an acquired disability. I am a traumatic brain injury survivor who needed extensive and continual care. I received care in five (5) different health care facilities in less than one (1) year and overall, seven (7) health care facilities for the treatment of the TBI. My presentation will highlight the importance of access to quality and continual care while also sharing the incredible health care professionals who were instrumental in my recovery.
F21.3.028 E&M Changes: Do You Select Medical Decision Making or Time?
Time 11:15 AM - 12:15 PM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Expert
CE Hours 1
Therapeutic Area(s)
Business/Professional
Speaker(s)
Lynn Rapsilber, DNP, APRN, ANP-BC, FAANP
There have been the most significant changes to E&M coding in over 30 years. This is a direct result of listening to clinicians. Patients over paperwork identified areas where documentation can be streamlined to reduce duplication and redundancy allowing for more time to attend to the patient. This presentation will walk through all the changes in detail. Selecting medical decision-making versus time will be reviewed. The participant will be able to maximize reimbursement through understanding and implementation of these changes.
F21.3.029 Primary Care Approach to Hypothyroidism
Time 11:15 AM - 12:15 PM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Endocrinology, Pharmacology, Primary Care
Speaker(s)
Susan S. VanBeuge, DNP, APRN, FNP-BC, FAANP
Hypothyroid disease is commonly managed in primary care. This presentation will take a methodical approach to the diagnosis, treatment, and ongoing management of the types of hypothyroid disease seen by primary care providers. We will detail the pharmacology and application of best practices when prescribing, titrating, and managing your patients’ hypothyroid needs.
F21.3.030 Rx Update: A 2021 Look at New Agents and Indications for Mood and Psychotic Disorders
Time 11:15 AM - 12:15 PM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Psychiatric/Mental Health
Speaker(s)
Sally K. Miller, PhD, APRN, FNP-BC, AGACNP-BC, AGPCNP-BC, PMHNP-BC, FAANP

Antipsychotic medication is a class always in revision. While all antipsychotics control psychoses, it is a never-ending challenge to minimize adverse effects; simultaneously new indications are consistently being developed. This presentation is designed for non-psychiatric providers who want to advance their skill set with respect to selection and application of antipsychotic and mood stabilizing medications in the primary care setting.

F21.3.036 Prevention of Cardiometabolic Disease
Time 2:00 PM - 3:00 PM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Cardiometabolic, Cardiovascular, Endocrinology, Obesity/Weight Management, Pharmacology, Primary Care, Social Determinants of Health
Speaker(s)
Allison W. Dimsdale, DNP, NP-C, AACC, FAANP
This presentation will focus on current evidence that defines risk for cardiometabolic disease. We will discuss cardiovascular disease, diabetes, and hyperlipidemia as they intersect in the pathophysiology and disease progression of cardiometabolic disease. We will discuss and apply case studies that illuminate both the prevention and treatment of atherosclerotic cardiovascular disease. This conversational session will include case study discussion and application for both the primary care provider and the specialist who aim to promote healthy aging.
F21.3.037 How to Strengthen Clinical Teams and Health Systems Through Allyship
Time 2:00 PM - 3:00 PM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Acute Care, Diversity Training and Cultural Competence, LGBT Health/Transgender, Primary Care, Social Determinants of Health
Speaker(s)
Courtney Pladsen, DNP, FNP-BC, RN
Nursing has an identity crisis. We must move beyond the comfort of our bubbles and well-meaning hashtags. There is a moral and business case for improving diversity in team composition, but how do we accomplish this without tokenizing? We will discuss how we can leverage our roles as allies to create inclusive and high functioning teams, which will ultimately better serve our communities.
F21.3.038 The Four C's: Candidates, Curriculum, Clinicals and Collaboration
Time 2:00 PM - 3:00 PM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Advanced Beginner
CE Hours 1
Therapeutic Area(s)
Business/Professional, Faculty Development/Education, Leadership, Primary Care, Transition to Practice
Speaker(s)
Grace Reilly Mazzatta, APN
This presentation will discuss Creating a Graduate Nurse Practitioner Residency Program. Does the literature accurately describe the needs of the new NPs? What does the literature say? Nurse practitioners are essential in primary care and have transitioned the delivery of health care across settings and populations. Nurse practitioners traditionally were RNS with several years of experience, including critical care experience, who advanced their education and degree in order to provide a higher level of care. This presentation will discuss current literature regarding residencies/fellowship programs for NPs. The presentation will outline steps to implement an NP residency, discuss the barriers/opportunities, the lessons learned along the way and the outcomes from our first cohort.
F21.3.039 Managing Type 2 Diabetes Mellitus: Beyond Metformin
Time 2:00 PM - 3:00 PM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Endocrinology, Pharmacology, Primary Care
Speaker(s)
Susan S. VanBeuge, DNP, APRN, FNP-BC, FAANP
Management of Type 2 Diabetes Mellitus is a complex and ever-changing landscape. Patients with type 2 diabetes mellitus have unique needs in a complex disease state. This presentation will review the practice guidelines and empower the nurse practitioner to improve outcomes with current treatment therapies available. This presentation will include application of case studies to illustrate use of practice guidelines and modifying treatment plans as needed.
F21.3.040 When the Patient Has Decided Cannabis is Their Medicine
Time 2:00 PM - 3:00 PM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Complementary/Alternative Therapy, Health Promotion/Wellness, Palliative/End-of-Life, Pharmacology, Psychiatric/Mental Health, Sleep Disorder
Speaker(s)
Andrew Penn, MS, PMHNP
In a time of increasing acceptance of cannabis, both as a medicine and as a recreational inebriant, many psychiatric clinicians encounter patients who use the drug, some of whom prefer cannabis to conventional psychiatric treatments. Contemporary clinicians need to be conversant in the latest knowledge of potential risks and benefits of cannabis. This presentation will examine what is known about both medical and recreational cannabis, utilizing a case-based approach, harm reduction, and motivational interviewing to partner with their patients who use cannabis.
F21.3.046 Managing Heart Failure in 2021: Implementing Guideline Recommendations into Practice
Time 3:15 PM - 4:15 PM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Acute Care, Cardiometabolic, Cardiovascular, Health Promotion/Wellness, Hospitalist/In-Patient, Pharmacology
Speaker(s)
Jennifer Ballard-Hernandez, DNP, FACC, FAHA, FAANP
Heart failure is a significant cause of cardiovascular morbidity and mortality in the United States. Nurse practitioners need to be knowledgeable of current treatment options to prevent cardiovascular sequela associated with heart failure. Using interactive case-based tutorials, participants will review the current American College of Cardiology/American Heart Association guideline on the management of heart failure, emphasizing practical approaches and clinical pearls to translate scientific evidence into everyday practice to improve patient outcomes. Emphasis will be on treatment goals based on recent evidence highlighting the importance guideline-directed medical therapy to reduce morbidity, mortality, and improve quality of life.
F21.3.047 The Professional World of Black, Indigenous, Latinx and Other Nurses of Color (BILNOC): Facing Racism
Time 3:15 PM - 4:15 PM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Diversity Training and Cultural Competence
Speaker(s)
Sheri Rickman Patrick, DNP, FNP-BC
The year 2020 shined a light on how pervasive and that systemic racism is alive and well in American institutions. Of course, health care is no different. The world has heard and learned much on how the social determinants, especially COVID, has been killing Black, Brown and Indigenous patients. While the health care profession is learning more and better ways to care for patients of color breaking down racist barriers facing patients, nursing, rated the most trusted profession the past two decades, is not exempt from systemic racism. Learn about the barriers facing Black, Brown and Indigenous students to being a nurse, how nurses and nurse practitioners of Color face racism in practice, education and research.
F21.3.048 NP Entrepreneurs as Risk Takers
Time 3:15 PM - 4:15 PM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Business/Professional
Speaker(s)
Lynn Rapsilber, DNP, APRN, ANP-BC, FAANP
The future of health care will depend upon nurse practitioners (NPs) taking the leap and becoming entrepreneurs. Many NPs are disenfranchised with the medical model of health care delivery focusing on numbers of patients seen as a measure of productivity. Couple this with the lack of primary care physicians, the reality of NPs creating a seismic shift in health care is inevitable. Nurse practitioner entrepreneurs (NPE) will need to understand the risks associated with business ownership and be willing to take them knowing they can be successful.
F21.3.049 Best Practices in Migraine Management
Time 3:15 PM - 4:15 PM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Convenient/Urgent Care, Emergency, Neurology, Pharmacology, Primary Care
Speaker(s)
Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP
Migraines affect approximately 13% of the population. They are associated with significant pain, suffering and disability. This presentation will provide the learner with the latest recommendations and guidelines regarding the management of patients with migraine and chronic migraine.
F21.3.050 Understanding Suicidality: Assessment, Treatment and Prevention for the Health Care Provider
Time 3:15 PM - 4:15 PM (Saturday, 9/25)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Addiction/Substance Abuse Disorder, Adolescent Health, Business/Professional, Health Promotion/Wellness, Military/Uniformed Services Health Care, Primary Care, Psychiatric/Mental Health
Speaker(s)
Rhone D’Errico, DNP, MBA, APRN, FNP-BC, ENP-C, PMHNP-BC, CNE

Repeated in F21.4.009. This presentation describes strategies that health care providers can utilize to understand, assess for, treat and prevent suicidality in diverse health care settings. The prevalence, epidemiology and psychology of suicidality will be reviewed, including a discussion of suicide among selected high-risk populations, including individuals who identify as LGBQ, veterans, minorities and health care professionals. This presentation includes approaches to training primary care office staff in suicide awareness and prevention. Safety planning, documentation and follow up are discussed, and self-care for the health care provider will be reviewed. The goal of this activity is to empower health care providers to confidently understand and address suicide risk in their specific patient populations.


Sunday, September 26
F21.4.006 2021 Clinical Practice Guidelines for Best Practice in the Management of Type 2 Diabetes Mellitus
Time 7:30 AM - 8:30 AM (Sunday, 9/26)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Cardiometabolic, Endocrinology, Pharmacology, Primary Care
Speaker(s)
Susan S. VanBeuge, DNP, APRN, FNP-BC, FAANP
The management of patients with type 2 diabetes mellitus is complex and dynamic. Clinical practice guidelines are updated by the American Diabetes Association yearly and require continuous provider learning to keep up with new research, technology, and treatment to improve outcomes and well-being for patient with diabetes. This presentation will review the 2021 guidelines and apply to current practice.
F21.4.007 Forum Theatre: Patient and Provider Bias
Time 7:30 AM - 11:00 AM (Sunday, 9/26)
Presentation Type Workshop
Content Level Advanced Beginner
CE Hours 3.25
Therapeutic Area(s)
Diversity Training and Cultural Competence
Speaker(s)
Faculty: Sandra Davis, PhD, DPM, ACNP-BC, FAANP; Jodi Kanter, PhD. Moderator: Danielle McCamey, DNP, CRNP, ACNP-BC, FCCP
In this session, Forum Theatre is used as an innovative, challenging, and thoughtful way to explore Racism, Bias and Discrimination. The workshop will include a critical analysis of Implicit Bias, Microaggressions, Systemic Racism, Privilege, Intersectionality, Disparities and Health Equity.
F21.4.008 The Business of Advanced Practice Nursing
Time 7:30 AM - 8:30 AM (Sunday, 9/26)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Business/Professional
Speaker(s)
Kevin Letz, DNP, MBA, APRN, CEN, CEN, FNP-BC, PNP, BC, ANP, BC, FAANP
The speaker will discuss the value equation of advanced nursing practice in today’s marketplace. He will review past and current payment models along with potential changes for advanced practice nursing in the next 10 years along with identifying potential opportunities.
F21.4.009 Understanding Suicidality: Assessment, Treatment and Prevention for the Health Care Provider
Time 7:30 AM - 8:30 AM (Sunday, 9/26)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Addiction/Substance Abuse Disorder, Adolescent Health, Business/Professional, Health Promotion/Wellness, Military/Uniformed Services Health Care, Primary Care, Psychiatric/Mental Health
Speaker(s)
Rhone D’Errico, DNP, MBA, APRN, FNP-BC, ENP-C, PMHNP-BC, CNE

Repeat of F21.3.050. This presentation describes strategies that health care providers can utilize to understand, assess for, treat and prevent suicidality in diverse health care settings. The prevalence, epidemiology and psychology of suicidality will be reviewed, including a discussion of suicide among selected high-risk populations, including individuals who identify as LGBQ, veterans, minorities and health care professionals. This presentation includes approaches to training primary care office staff in suicide awareness and prevention. Safety planning, documentation and follow up are discussed, and self-care for the health care provider will be reviewed. The goal of this activity is to empower health care providers to confidently understand and address suicide risk in their specific patient populations.

F21.4.010 WHY OR WHY NOT: Recovery Engagement in Primary Care
Time 7:30 AM - 8:30 AM (Sunday, 9/26)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Addiction/Substance Abuse Disorder, Health Promotion/Wellness, Integrative Health, Pharmacology, Primary Care, Psychiatric/Mental Health
Speaker(s)
Robert White, DNP, APN, PMHNP-BC, FNP-BC
Effectively treating a primary care patient’s substance abuse problem is addressing a significant personal health care need. Recovery engagement in primary care settings that integrate addiction treatment with primary health care are needed now more than ever. It is essential as we understand substance use disorder to be a chronic illness requiring ongoing recovery management rather than isolated episodes of treatment. There has been a shift in health care to emphasize both effectiveness and lower costs which is the true LINKAGE within recovery engagement within the primary care setting.
F21.4.016 What is Cardiorenal Syndrome and When Should I Worry?
Time 8:45 AM - 9:45 AM (Sunday, 9/26)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Acute Care, Cardiometabolic, Cardiovascular, Hospitalist/In-Patient, Nephrology, Primary Care
Speaker(s)
Carolina D. Tennyson, DNP, ACNP-BC, AACC
This presentation will clearly describe what is known about the types of cardiorenal syndrome and review heart-kidney pathophysiology. Diagnosis and management will be discussed in the context of both primary and acute care populations. Clinical application will be demonstrated with the use of case studies.
F21.4.018 Income Diversification and Tax Strategies
Time 8:45 AM - 9:45 AM (Sunday, 9/26)
Presentation Type Concurrent Presentation
Content Level Expert
CE Hours 1
Therapeutic Area(s)
Business/Professional
Speaker(s)
Kevin Letz, DNP, MBA, APRN, CEN, CEN, FNP-BC, PNP, BC, ANP, BC, FAANP
The speaker will review various mechanisms to diversify income generation outside of full-time employment. This review will include investing, side hustles, and owning a small business. He will discuss the benefit of alternative income strategies on taxes and also various strategies to reduce your tax burden.
F21.4.019 Vaccines in 2021: Covid-19 and Beyond
Time 8:45 AM - 9:45 AM (Sunday, 9/26)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Adolescent Health, COVID 19, Gerontology, Infectious Disease, Pharmacology, Primary Care
Speaker(s)
Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP
This lecture will provide the latest updates and guidelines regarding vaccinations across the lifespan. Discussion regarding Covid-19 vaccines and their efficacy will also be discussed.
F21.4.020 Caring Science Meets Psychedelic-assisted Psychotherapy
Time 8:45 AM - 9:45 AM (Sunday, 9/26)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Complementary/Alternative Therapy, Integrative Health, Pharmacology, Psychiatric/Mental Health
Speaker(s)
Andrew Penn, MS, PMHNP
Psychedelic assisted therapy (i.e., psilocybin for depression and MDMA for PTSD) are under study in phase 2 and 3 FDA registry trials. These treatments utilize a combination of psychotherapy and 1-3 treatments with psychedelic medicines to catalyze therapeutic outcomes. A key aspect to this treatment is the therapeutic container created between the patient, the therapist(s), and the medicine. Nurses and nurse practitioners, with a focus on patient care, are well suited to the subtle work of “guiding” a psychedelic session. This presentation will highlight a recently authored model of care informed psychedelic therapy, blending the theoretical work of a leading theorist in psychedelic therapy with the well-known nursing Caritas Principles of Jean Watson, delivered by a leading nurse in this emerging therapeutic modality.
F21.4.026 Inpatient Diabetes Management: An Opportunity to Optimize
Time 10:00 AM - 11:00 AM (Sunday, 9/26)
Presentation Type Concurrent Presentation
Content Level Expert
CE Hours 1
Therapeutic Area(s)
Acute Care, Cardiometabolic, Endocrinology, Hospitalist/In-Patient, Pharmacology
Speaker(s)
Melanie E. Mabrey, DNP, ACNP-BC, BC-ADM, FAANP

Current evidence shows glycemic control is essential in decreasing inpatient mortality and morbidity particularly in the cardiometabolic patient, yet studies are limited in number and size in the most effective way to do this outside of intravenous insulin. Care of the patient with hyperglycemia and/or diabetes in the hospital setting can be daunting. This presentation will focus on safely and aggressively treating blood glucoses to target using insulin therapies. Cases will cover initiating and individualizing insulin therapy in various patient populations. Specific cardiology patient examples will be provided on troubleshooting difficult intravenous insulin titrations, transitioning from intravenous to subcutaneous insulin, and dealing with NPO status, tube feedings, TPN, steroids and patients with chronic kidney or end-stage renal disease.

F21.4.028 The Best Businesses to Start for Less Than 2K
Time 10:00 AM - 11:00 AM (Sunday, 9/26)
Presentation Type Concurrent Presentation
Content Level Expert
CE Hours 1
Therapeutic Area(s)
Business/Professional
Speaker(s)
Scharmaine M. Lawson-Baker, DNP, FNP-BC, FAANP, FAAN
Have you ever wanted to start a business but stopped thinking about doing so because of the price? Well, good news! This presentation will outline three business ideas for an NP to start for less than 2K.
F21.4.029 Uncovering Disparities in the Care of Persons with Kidney Disease
Time 10:00 AM - 11:00 AM (Sunday, 9/26)
Presentation Type Concurrent Presentation
Content Level Competent
CE Hours 1
Therapeutic Area(s)
Diversity Training and Cultural Competence, Nephrology, Social Determinants of Health
Speaker(s)
Nancy Uhland, DNP, FNP-C
Utilizing the feature of one’s race is frequently used in the care of persons with kidney disease. But is there a place for race-based medicine? Does using race-based medicine place Black persons at-risk for receiving delayed care or contribute to the fact Black persons have a longer waiting time on the kidney transplant list? Together, we will uncover opportunities to eliminate disparities in caring for persons with kidney disease and address inequalities in kidney health.
F21.4.030 Order from Chaos: Trauma-informed Leadership
Time 10:00 AM - 11:00 AM (Sunday, 9/26)
Presentation Type Concurrent Presentation
Content Level Proficient
CE Hours 1
Therapeutic Area(s)
Business/Professional, Emergency, Leadership, Psychiatric/Mental Health
Speaker(s)
Rhone D’Errico, DNP, MBA, APRN, FNP-BC, ENP-C, PMHNP-BC, CNE
This presentation will examine the role of the nurse practitioner leader in disaster situations, from preparation to the event itself, and through the aftermath. Concepts related to leadership style, management of healthcare resources and personnel, communication, and care for survivors and caregivers will be discussed. The Las Vegas mass casualty event of October 1, 2017 will serve as the case study for these concepts.